53
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer

, , , , &
Pages 4413-4422 | Published online: 11 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yi Ji, Jialin Gu, Hongqun Zhang & Houxi Xu. (2023) Identification and Validation of Key miRNAs for Colon Cancer Based on miRNA-Gene Integration Analysis. International Journal of General Medicine 16, pages 5703-5718.
Read now
Qifu Yang, Miku Miyagawa, Xiaoyang Liu, Beiwei Zhu, Shintaro Munemasa, Toshiyuki Nakamura, Yoshiyuki Murata & Yoshimasa Nakamura. (2018) Methyl-β-cyclodextrin potentiates the BITC-induced anti-cancer effect through modulation of the Akt phosphorylation in human colorectal cancer cells. Bioscience, Biotechnology, and Biochemistry 82:12, pages 2158-2167.
Read now

Articles from other publishers (15)

Mathieu Chocry, Ludovic Leloup, Fabrice Parat, Mélissa Messé, Alessandra Pagano & Hervé Kovacic. (2022) Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer. Cancers 14:23, pages 5894.
Crossref
Bettina Bohusné Barta, Ágnes Simon, Lőrinc Nagy, Titanilla Dankó, Regina Eszter Raffay, Gábor Petővári, Viktória Zsiros, Anna Sebestyén, Ferenc Sipos & Györgyi Műzes. (2022) Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response. PLOS ONE 17:5, pages e0268217.
Crossref
Yu-Chih Chen, Yin-Siew Lai, Yan-Der Hsuuw & Ko-Tung Chang. (2021) Withholding of M-CSF Supplement Reprograms Macrophages to M2-Like via Endogenous CSF-1 Activation. International Journal of Molecular Sciences 22:7, pages 3532.
Crossref
Pradip Shahi Thakuri, Astha Lamichhane, Sunil Singh, Megha Gupta, Gary D. Luker & Hossein Tavana. (2020) Modeling Adaptive Resistance of KRAS Mutant Colorectal Cancer to MAPK Pathway Inhibitors with a Three-Dimensional Tumor Model. ACS Pharmacology & Translational Science 3:6, pages 1176-1187.
Crossref
Kyung‐Eun Lim, April M. Hoggatt, Whitney A. Bullock, Daniel J. Horan, Hiroki Yokota, Frederick M. Pavalko & Alexander G. Robling. (2020) Pten deletion in Dmp1‐expressing cells does not rescue the osteopenic effects of Wnt/β‐catenin suppression. Journal of Cellular Physiology 235:12, pages 9785-9794.
Crossref
Guoliang Li, Thanigaivelan Kanagasabai, Wenfu Lu, Mike R. Zou, Shang-Min Zhang, Sherly I. Celada, Michael G. Izban, Qi Liu, Tao Lu, Billy R. Ballard, Xinchun Zhou, Samuel E. Adunyah, Robert J. Matusik, Qin Yan & Zhenbang Chen. (2020) KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis. Cancer Research 80:21, pages 4633-4643.
Crossref
Maged. W. Helmy, Asser I. Ghoneim, Mohamed A. Katary & Rana K. Elmahdy. (2020) The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis. Molecular Biology Reports 47:3, pages 2217-2230.
Crossref
Dorota Ciołczyk-Wierzbicka, Dorota Gil, Marta Zarzycka & Piotr Laidler. (2019) mTOR inhibitor everolimus reduces invasiveness of melanoma cells. Human Cell 33:1, pages 88-97.
Crossref
Dorota Ciołczyk-Wierzbicka, Marta Zarzycka, Dorota Gil & Piotr Laidler. (2019) mTOR inhibitor Everolimus-induced apoptosis in melanoma cells. Journal of Cell Communication and Signaling 13:3, pages 357-368.
Crossref
Nan Wu, Mingzuo Jiang, Yuying Han, Haiming Liu, Yi Chu, Hao Liu, Jiayi Cao, Qiuqiu Hou, Yu Zhao, Bing Xu & Xin Xie. (2019) O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5. Journal of Cellular and Molecular Medicine 23:2, pages 1354-1362.
Crossref
Chenbo Ding, Wendong Tang, Hailu Wu, Xiaobo Fan, Junmin Luo, Jihong Feng, Kunming Wen & Guoqiu Wu. (2019) The PEAK1–PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer. Cancer Letters 442, pages 383-395.
Crossref
Kuo-Wang Tsai, Yi-Hao Lo, Hsuan Liu, Chung-Yu Yeh, You-Zuo Chen, Chao-Wen Hsu, Wei-Shone Chen & Jui-Ho Wang. (2018) Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer. Molecular Cancer 17:1.
Crossref
Ewa Toton, Aleksandra Romaniuk, Natalia Konieczna, Johann Hofmann, Jan Barciszewski & Maria Rybczynska. (2018) Impact of PKCε downregulation on autophagy in glioblastoma cells. BMC Cancer 18:1.
Crossref
Dan Li, Gangcheng Wang, Guoguo Jin, Ke Yao, Zhenjiang Zhao, Liangyu Bie, Yongjun Guo, Ning Li, Wenying Deng, Xiaobin Chen, Beibei Chen, Yuanyuan Liu, Suxia Luo & Zhiping Guo. (2018) Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway. International Journal of Molecular Medicine.
Crossref
Hui Yao, Song Su, Dong Xia, Mingming Wang, Zonglin Li, Wangsheng Chen, Lei Ren & Liang Xu. (2018) F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway. Biomedicine & Pharmacotherapy 107, pages 1712-1719.
Crossref